P3 Health Partners (PIII) Depreciation & Amortization (CF) (2021 - 2025)

P3 Health Partners has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $21.0 million in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 0.75% year-over-year to $21.0 million; the trailing twelve-month figure through Dec 2025 stood at $84.2 million (down 2.2% YoY), and the FY2025 full-year result was $84.2 million, down 2.2% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $21.0 million, roughly flat from $21.0 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $22.0 million in Q4 2022, with the low at $332548.0 in Q1 2021.
• Historically, Depreciation & Amortization (CF) has averaged $18.2 million across 5 years, with a median of $21.5 million in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 6441.01% — and 2025, when it fell 2.95%.
• P3 Health Partners' Depreciation & Amortization (CF) stood at $456418.0 in 2021, then surged by 4720.58% to $22.0 million in 2022, then retreated by 1.67% to $21.6 million in 2023, then retreated by 2.22% to $21.2 million in 2024, then decreased by 0.75% to $21.0 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $21.0 million (Q4 2025), $21.0 million (Q3 2025), and $21.1 million (Q2 2025), per Business Quant data.